Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Barred From Agreeing ‘No-Authorized Generics’ Deals Under Reverse-Payment FTC Settlement
Feb 20 2019
•
By
Dean Rudge
Teva Has Struck A Deal With The FTC To Resolve Pending Claims In Three Cases • Source: Shutterstock
More from Strategy
More from Business